When and where is the conference going to be organized?

The 2nd Edition of the Cancer R&D World Conference will be held from September 21–23, 2026, in Miami, Florida, USA.

When does enrollment for the CRDWC 2026 conference start?

CRDWC 2026 registration opens on September 25th, 2025 and you can register through the following link: https://www.cancerglobalconference.com/registration

What does the registration fee include?

In-person participants can avail: Full access to all abstract books, scientific sessions, keynotes, and panel discussions. Entry to poster and exhibition areas. Access to the networking sessions and welcome reception. Conference materials (digital program, ID badge, and certificate of participation). Coffee breaks and lunch during the conference days. Note: Participants registered only for participation are not allowed to present their oral or poster presentations. The virtual (online) participants can avail: Participants can present their research online from the convenience of their home or workplace. Full virtual access to all conference sessions, including keynotes, oral presentations, and panel discussions. A downloadable E-book of abstracts containing all accepted papers and presentations. An official E-certificate of presentation and participation, issued electronically after the conference.

Do group registrants receive any discounts?

Yes, we offer discounts to the group registrations. For group registrations, please contact our registration team at info@precisionglobalconferences.com for group discounts.

How can I submit an abstract?

You can submit the abstracts in accordance with the instructions. The webpage contains information about the format and rules. You can submit the abstracts via email or weblink. Email: cancer@precisionglobalconferences.com Weblink: https://www.cancerglobalconference.com/abstract-submission

How much time will be given for an oral presentation?

Each oral presenter will have 20 to 25 minutes in total — 20 minutes for presentation and 5 minutes for audience questions and discussion. With regard to the poster presentations, you will have 10 to 15 minutes to complete your presentation along with questions and discussion.

What language should I use during my presentation?

The official language of the conference is English. All oral and poster presentations must be delivered in English to ensure consistency and engagement among our international audience.

How can I become a sponsor or exhibitor?

If you are interested in the sponsorship or exhibitor, please do reach out at sponsors@precisionglobalconferences.com

How long will it take to receive a response after submitting my abstract?

You will receive an acknowledgment email immediately after submission. The review process typically takes 2–4 days. If you haven’t received any communication, please reach us by email: cancer@precisionglobalconferences.com

How I can request a visa invitation letter?

After completion of the registration process, you will receive the visa invitation letter. If you didn't receive the visa invitation letter, please email us at: cancer@precisionglobalconferences.com

3ʳᵈ Edition of the Cancer R&D World Conference 2027

San Diego, CA, USA

September 2027

+1-571-5561014

cancer@precisionglobalconferences.com

Hybrid Event

+1-571-5561014
Phone
cancer@precisionglobalconferences.com
Mail to us
San Diego, CA, USA
Address

3ʳᵈ Edition of the Cancer R&D World Conference 2027

San Diego, CA, USA

September 2027

Scientific Sessions - CRDWC 2026

Advances in Nanotechnology for Cancer Treatment

Cellular Therapies Beyond CAR-T

The Role of Epigenetics in Cancer Diagnosis

Current Landscape and Future Directions of Oncology Research

Oncogenic Signaling Pathways and Therapeutic Targets

Emerging Biomarkers for Cancer Detection and Prognosis

Cancer Prevention and Early Detection Strategies

Immuno Oncology and Cell Based Therapies

Innovations in Immuno Oncology

Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy

Cancer Vaccines

CAR T Cell Therapy: Clinical Progress and Challenges

Next Generation Cell and Gene Therapies in Oncology

Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics

Companion Diagnostics

Artificial Intelligence and Machine Learning in Precision Oncology

Next Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS

Overcoming Drug Resistance: Mechanisms and Solutions

Oncology Pipeline

Trends in Antibody Drug Conjugates (ADCs)

Launch of Novel mAb Products for Cancer Therapy

Useful Links

Venue Details

San Diego, CA, USA

Organizer

Precision Global Conferences